Adtalem Global Education (NYSE:CVSA) Cut to Hold at Wall Street Zen

Wall Street Zen lowered shares of Adtalem Global Education (NYSE:CVSA) from a buy rating to a hold rating in a research report released on Saturday.

Other equities analysts also recently issued research reports about the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Adtalem Global Education in a research note on Friday, May 22nd. Truist Financial lifted their target price on Adtalem Global Education from $130.00 to $140.00 and gave the stock a “buy” rating in a research report on Monday, May 11th. Finally, Barrington Research reissued an “outperform” rating and issued a $170.00 target price on shares of Adtalem Global Education in a report on Monday, June 8th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Adtalem Global Education has a consensus rating of “Moderate Buy” and a consensus target price of $155.00.

Adtalem Global Education Trading Up 3.9%

Shares of Adtalem Global Education stock opened at $120.38 on Friday. The firm has a fifty day moving average of $123.66. Adtalem Global Education has a 12-month low of $86.97 and a 12-month high of $156.26. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The firm has a market cap of $4.10 billion, a PE ratio of 18.75, a price-to-earnings-growth ratio of 0.87 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last posted its earnings results on Thursday, May 7th. The company reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $487.03 million for the quarter. During the same period last year, the business earned $1.92 earnings per share. The company’s quarterly revenue was up 4.5% on a year-over-year basis. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, analysts forecast that Adtalem Global Education will post 8.04 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Adtalem Global Education news, insider Karen Sue Cox sold 2,000 shares of the business’s stock in a transaction on Friday, May 8th. The shares were sold at an average price of $124.50, for a total value of $249,000.00. Following the transaction, the insider directly owned 31,596 shares of the company’s stock, valued at approximately $3,933,702. The trade was a 5.95% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 10,000 shares of the firm’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $126.21, for a total transaction of $1,262,100.00. Following the completion of the sale, the chief financial officer owned 55,806 shares of the company’s stock, valued at $7,043,275.26. This trade represents a 15.20% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 53,183 shares of company stock worth $6,914,570. 2.50% of the stock is currently owned by company insiders.

About Adtalem Global Education

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.